The global Inherited Cancer Genome Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Inherited Cancer Genome Testing in General Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Inherited Cancer Genome Testing include 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Inherited Cancer Genome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inherited Cancer Genome Testing.

Report Scope

The Inherited Cancer Genome Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inherited Cancer Genome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inherited Cancer Genome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inherited Cancer Genome Testing Market Report

Report Metric	Details
Report Name	Inherited Cancer Genome Testing Market
Segment by Type	Breast Cancer Lung Cancer Blood Cancer Liver Cancer Stomach Cancer Others
Segment by Application	General Hospitals Specialty Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp, Myriad Genetics, Positive Bioscience, Quest Diagnostics, Thermo Fisher Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inherited Cancer Genome Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Inherited Cancer Genome Testing Market report?

Ans: The main players in the Inherited Cancer Genome Testing Market are 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp, Myriad Genetics, Positive Bioscience, Quest Diagnostics, Thermo Fisher Scientific

What are the Application segmentation covered in the Inherited Cancer Genome Testing Market report?

Ans: The Applications covered in the Inherited Cancer Genome Testing Market report are General Hospitals, Specialty Clinics

What are the Type segmentation covered in the Inherited Cancer Genome Testing Market report?

Ans: The Types covered in the Inherited Cancer Genome Testing Market report are Breast Cancer, Lung Cancer, Blood Cancer, Liver Cancer, Stomach Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Breast Cancer

1.2.3 Lung Cancer

1.2.4 Blood Cancer

1.2.5 Liver Cancer

1.2.6 Stomach Cancer

1.2.7 Others

1.3 Market by Application

1.3.1 Global Inherited Cancer Genome Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 General Hospitals

1.3.3 Specialty Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Inherited Cancer Genome Testing Market Perspective (2019-2030)

2.2 Inherited Cancer Genome Testing Growth Trends by Region

2.2.1 Global Inherited Cancer Genome Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Inherited Cancer Genome Testing Historic Market Size by Region (2019-2024)

2.2.3 Inherited Cancer Genome Testing Forecasted Market Size by Region (2025-2030)

2.3 Inherited Cancer Genome Testing Market Dynamics

2.3.1 Inherited Cancer Genome Testing Industry Trends

2.3.2 Inherited Cancer Genome Testing Market Drivers

2.3.3 Inherited Cancer Genome Testing Market Challenges

2.3.4 Inherited Cancer Genome Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Inherited Cancer Genome Testing Players by Revenue

3.1.1 Global Top Inherited Cancer Genome Testing Players by Revenue (2019-2024)

3.1.2 Global Inherited Cancer Genome Testing Revenue Market Share by Players (2019-2024)

3.2 Global Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Inherited Cancer Genome Testing Revenue

3.4 Global Inherited Cancer Genome Testing Market Concentration Ratio

3.4.1 Global Inherited Cancer Genome Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inherited Cancer Genome Testing Revenue in 2023

3.5 Inherited Cancer Genome Testing Key Players Head office and Area Served

3.6 Key Players Inherited Cancer Genome Testing Product Solution and Service

3.7 Date of Enter into Inherited Cancer Genome Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Inherited Cancer Genome Testing Breakdown Data by Type

4.1 Global Inherited Cancer Genome Testing Historic Market Size by Type (2019-2024)

4.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2025-2030)

5 Inherited Cancer Genome Testing Breakdown Data by Application

5.1 Global Inherited Cancer Genome Testing Historic Market Size by Application (2019-2024)

5.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Inherited Cancer Genome Testing Market Size (2019-2030)

6.2 North America Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Inherited Cancer Genome Testing Market Size by Country (2019-2024)

6.4 North America Inherited Cancer Genome Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Inherited Cancer Genome Testing Market Size (2019-2030)

7.2 Europe Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Inherited Cancer Genome Testing Market Size by Country (2019-2024)

7.4 Europe Inherited Cancer Genome Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Inherited Cancer Genome Testing Market Size (2019-2030)

8.2 Asia-Pacific Inherited Cancer Genome Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Inherited Cancer Genome Testing Market Size (2019-2030)

9.2 Latin America Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Inherited Cancer Genome Testing Market Size by Country (2019-2024)

9.4 Latin America Inherited Cancer Genome Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Inherited Cancer Genome Testing Market Size (2019-2030)

10.2 Middle East & Africa Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 23andMe

11.1.1 23andMe Company Detail

11.1.2 23andMe Business Overview

11.1.3 23andMe Inherited Cancer Genome Testing Introduction

11.1.4 23andMe Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.1.5 23andMe Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Inherited Cancer Genome Testing Introduction

11.2.4 Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.2.5 Agilent Technologies Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Detail

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Introduction

11.3.4 Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Centogene

11.4.1 Centogene Company Detail

11.4.2 Centogene Business Overview

11.4.3 Centogene Inherited Cancer Genome Testing Introduction

11.4.4 Centogene Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.4.5 Centogene Recent Development

11.5 Color Genomics

11.5.1 Color Genomics Company Detail

11.5.2 Color Genomics Business Overview

11.5.3 Color Genomics Inherited Cancer Genome Testing Introduction

11.5.4 Color Genomics Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.5.5 Color Genomics Recent Development

11.6 Gene By Gene

11.6.1 Gene By Gene Company Detail

11.6.2 Gene By Gene Business Overview

11.6.3 Gene By Gene Inherited Cancer Genome Testing Introduction

11.6.4 Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.6.5 Gene By Gene Recent Development

11.7 Illumina

11.7.1 Illumina Company Detail

11.7.2 Illumina Business Overview

11.7.3 Illumina Inherited Cancer Genome Testing Introduction

11.7.4 Illumina Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.7.5 Illumina Recent Development

11.8 LabCorp

11.8.1 LabCorp Company Detail

11.8.2 LabCorp Business Overview

11.8.3 LabCorp Inherited Cancer Genome Testing Introduction

11.8.4 LabCorp Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.8.5 LabCorp Recent Development

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Detail

11.9.2 Myriad Genetics Business Overview

11.9.3 Myriad Genetics Inherited Cancer Genome Testing Introduction

11.9.4 Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.9.5 Myriad Genetics Recent Development

11.10 Positive Bioscience

11.10.1 Positive Bioscience Company Detail

11.10.2 Positive Bioscience Business Overview

11.10.3 Positive Bioscience Inherited Cancer Genome Testing Introduction

11.10.4 Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.10.5 Positive Bioscience Recent Development

11.11 Quest Diagnostics

11.11.1 Quest Diagnostics Company Detail

11.11.2 Quest Diagnostics Business Overview

11.11.3 Quest Diagnostics Inherited Cancer Genome Testing Introduction

11.11.4 Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.11.5 Quest Diagnostics Recent Development

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Detail

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Inherited Cancer Genome Testing Introduction

11.12.4 Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2019-2024)

11.12.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Breast Cancer

Table 3. Key Players of Lung Cancer

Table 4. Key Players of Blood Cancer

Table 5. Key Players of Liver Cancer

Table 6. Key Players of Stomach Cancer

Table 7. Key Players of Others

Table 8. Global Inherited Cancer Genome Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Inherited Cancer Genome Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Inherited Cancer Genome Testing Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Inherited Cancer Genome Testing Market Share by Region (2019-2024)

Table 12. Global Inherited Cancer Genome Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Inherited Cancer Genome Testing Market Share by Region (2025-2030)

Table 14. Inherited Cancer Genome Testing Market Trends

Table 15. Inherited Cancer Genome Testing Market Drivers

Table 16. Inherited Cancer Genome Testing Market Challenges

Table 17. Inherited Cancer Genome Testing Market Restraints

Table 18. Global Inherited Cancer Genome Testing Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Inherited Cancer Genome Testing Market Share by Players (2019-2024)

Table 20. Global Top Inherited Cancer Genome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2023)

Table 21. Ranking of Global Top Inherited Cancer Genome Testing Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Inherited Cancer Genome Testing Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Inherited Cancer Genome Testing Product Solution and Service

Table 25. Date of Enter into Inherited Cancer Genome Testing Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Inherited Cancer Genome Testing Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2019-2024)

Table 29. Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2025-2030)

Table 31. Global Inherited Cancer Genome Testing Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Inherited Cancer Genome Testing Revenue Market Share by Application (2019-2024)

Table 33. Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Inherited Cancer Genome Testing Revenue Market Share by Application (2025-2030)

Table 35. North America Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Inherited Cancer Genome Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)

Table 50. 23andMe Company Detail

Table 51. 23andMe Business Overview

Table 52. 23andMe Inherited Cancer Genome Testing Product

Table 53. 23andMe Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 54. 23andMe Recent Development

Table 55. Agilent Technologies Company Detail

Table 56. Agilent Technologies Business Overview

Table 57. Agilent Technologies Inherited Cancer Genome Testing Product

Table 58. Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 59. Agilent Technologies Recent Development

Table 60. Bio-Rad Laboratories Company Detail

Table 61. Bio-Rad Laboratories Business Overview

Table 62. Bio-Rad Laboratories Inherited Cancer Genome Testing Product

Table 63. Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 64. Bio-Rad Laboratories Recent Development

Table 65. Centogene Company Detail

Table 66. Centogene Business Overview

Table 67. Centogene Inherited Cancer Genome Testing Product

Table 68. Centogene Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 69. Centogene Recent Development

Table 70. Color Genomics Company Detail

Table 71. Color Genomics Business Overview

Table 72. Color Genomics Inherited Cancer Genome Testing Product

Table 73. Color Genomics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 74. Color Genomics Recent Development

Table 75. Gene By Gene Company Detail

Table 76. Gene By Gene Business Overview

Table 77. Gene By Gene Inherited Cancer Genome Testing Product

Table 78. Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 79. Gene By Gene Recent Development

Table 80. Illumina Company Detail

Table 81. Illumina Business Overview

Table 82. Illumina Inherited Cancer Genome Testing Product

Table 83. Illumina Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 84. Illumina Recent Development

Table 85. LabCorp Company Detail

Table 86. LabCorp Business Overview

Table 87. LabCorp Inherited Cancer Genome Testing Product

Table 88. LabCorp Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 89. LabCorp Recent Development

Table 90. Myriad Genetics Company Detail

Table 91. Myriad Genetics Business Overview

Table 92. Myriad Genetics Inherited Cancer Genome Testing Product

Table 93. Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 94. Myriad Genetics Recent Development

Table 95. Positive Bioscience Company Detail

Table 96. Positive Bioscience Business Overview

Table 97. Positive Bioscience Inherited Cancer Genome Testing Product

Table 98. Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 99. Positive Bioscience Recent Development

Table 100. Quest Diagnostics Company Detail

Table 101. Quest Diagnostics Business Overview

Table 102. Quest Diagnostics Inherited Cancer Genome Testing Product

Table 103. Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 104. Quest Diagnostics Recent Development

Table 105. Thermo Fisher Scientific Company Detail

Table 106. Thermo Fisher Scientific Business Overview

Table 107. Thermo Fisher Scientific Inherited Cancer Genome Testing Product

Table 108. Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)

Table 109. Thermo Fisher Scientific Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Inherited Cancer Genome Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Inherited Cancer Genome Testing Market Share by Type: 2023 VS 2030

Figure 3. Breast Cancer Features

Figure 4. Lung Cancer Features

Figure 5. Blood Cancer Features

Figure 6. Liver Cancer Features

Figure 7. Stomach Cancer Features

Figure 8. Others Features

Figure 9. Global Inherited Cancer Genome Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Inherited Cancer Genome Testing Market Share by Application: 2023 VS 2030

Figure 11. General Hospitals Case Studies

Figure 12. Specialty Clinics Case Studies

Figure 13. Inherited Cancer Genome Testing Report Years Considered

Figure 14. Global Inherited Cancer Genome Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Inherited Cancer Genome Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Inherited Cancer Genome Testing Market Share by Region: 2023 VS 2030

Figure 17. Global Inherited Cancer Genome Testing Market Share by Players in 2023

Figure 18. Global Top Inherited Cancer Genome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Inherited Cancer Genome Testing Revenue in 2023

Figure 20. North America Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Inherited Cancer Genome Testing Market Share by Country (2019-2030)

Figure 22. United States Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Inherited Cancer Genome Testing Market Share by Country (2019-2030)

Figure 26. Germany Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Inherited Cancer Genome Testing Market Share by Region (2019-2030)

Figure 34. China Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Inherited Cancer Genome Testing Market Share by Country (2019-2030)

Figure 42. Mexico Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Inherited Cancer Genome Testing Market Share by Country (2019-2030)

Figure 46. Turkey Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. 23andMe Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 49. Agilent Technologies Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 51. Centogene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 52. Color Genomics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 53. Gene By Gene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 54. Illumina Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 55. LabCorp Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 56. Myriad Genetics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 57. Positive Bioscience Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 58. Quest Diagnostics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Gene Test Service Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-37C5753

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Electrophoretic Transmissometer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-24D14445

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid Vaccine Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-10U8455

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Sequencing Gene Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22G18536

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions